$12.610
-0.322 (-2.55%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TRVI por análisis de gráficos similares
Alphio's TRVI stock price prediction model matches the current Trevi Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.49 (-0.94%). The 1-week path is $12.93 (+2.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Trevi Therapeutics Inc?
Trevi Therapeutics Inc appears to be a good buy right now due to its current price of $12.61, which is well below the analyst price targets of $20 to $36. The company has a strong cash position of approximately $319 million, ensuring operational stability into 2030, which supports its ongoing clinical trials and market competitiveness. However, the main risk is the negative earnings trend, with a projected EPS of -0.11 for Q2 2026, indicating continued losses in the near term.
TRVI cerró en $12.61 el Friday, tras bajar -2.55%
Trevi Therapeutics Inc (TRVI) last closed at $12.61, losing -2.55%. These facts feed the 1-day and 1-week TRVI price prediction above.
Factores de la previsión
Los factores de la previsión de Trevi Therapeutics Inc (TRVI) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TRVI, ordenadas por similitud.
Análisis de estacionalidad de TRVI
Historically the probability of a positive October return for TRVI is 98.41%. May offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TRVI
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $6.23 | $6.86 | $7.76 | -45.61% |
| Nov 2026 | $5.82 | $6.12 | $7.19 | -51.45% |
| Dec 2026 | $5.27 | $6.52 | $7.16 | -48.26% |
En 2026, se proyecta que Trevi Therapeutics Inc (TRVI) oscile entre $5.27 y $7.76.
Previsión mensual de Trevi Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Trevi Therapeutics Inc promedie $6.86, con un mínimo de $6.23 y un máximo de $7.76.
En Nov de 2026, se proyecta que Trevi Therapeutics Inc promedie $6.12, con un mínimo de $5.82 y un máximo de $7.19.
En Dec de 2026, se proyecta que Trevi Therapeutics Inc promedie $6.52, con un mínimo de $5.27 y un máximo de $7.16.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.